mRNA: A New Frontier In Vaccines And Medicine

Vaccines global clinical development experts Vanessa Elharrar, Martina Kovac and Anusha Streubel discuss how groundbreaking mRNA technology has ushered in a new era of vaccines and therapeutics development in this American Pharmaceutical Review feature.

Authors:

• Vanessa Elharrar, MD, vice president, vaccines business strategy lead, PPD Clinical Research Services, Thermo Fisher Scientific
• Martina Kovac, MD, vice president, vaccines global product development, PPD Clinical Research Services, Thermo Fisher Scientific
• Anusha Streubel, MD, vaccines executive medical director, PPD Clinical Research Services, Thermo Fisher Scientific